OPHLF - Ono Pharmaceutical Co., Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
Total revenue
428,951,000
361,361,000
309,284,000
292,420,000
Cost of revenue
106,664,000
93,511,000
85,573,000
79,063,000
Gross profit
322,287,000
267,850,000
223,711,000
213,356,000
Operating expenses
Research development
92,389,000
75,879,000
62,384,000
66,497,000
Selling general and administrative
85,716,000
77,057,000
69,230,000
67,679,000
Total operating expenses
178,669,000
164,654,000
125,381,000
135,866,000
Operating income or loss
143,618,000
103,196,000
98,330,000
77,490,000
Interest expense
1,145,000
874,000
137,000
845,000
Income before tax
145,055,000
105,025,000
100,890,000
79,696,000
Income tax expense
33,211,000
24,340,000
25,392,000
19,808,000
Income from continuing operations
111,844,000
80,685,000
75,498,000
59,888,000
Net income
111,555,000
80,519,000
75,425,000
59,704,000
Net income available to common shareholders
111,555,000
80,519,000
75,425,000
59,704,000
Basic EPS
-
162.19
151.11
118.47
Diluted EPS
-
162.16
151.09
118.45
Basic average shares
-
496,459
499,137
503,975
Diluted average shares
-
496,527
499,203
504,044
EBITDA
-
123,620,000
116,847,000
94,755,000